INTERNATIONAL PATENT: VASOPHARMA AB FILES APPLICATION FOR "COMBINATION TREATMENTS OF MEK AND PKC INHIBITORS"

GENEVA, Dec. 22 -- VASOPHARMA AB (C/o Niclas LundqvistSundviksvagen 126261 63 GLUMSLOV) filed a patent application (PCT/EP2025/066653) for "COMBINATION TREATMENTS OF MEK AND PKC INHIBITORS" on Jun 13, 2025. With publication no. WO/2025/257422, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EDVINSSON, Lars (Sundviksvagen 126261 63 Glumslov)

Abstract: The invention provides a MEK inhibitor for use in the treatment or prophylaxis of a cardiovascular or respiratory disease or disorder, wherein the MEK inhibitor is administe...